AzTrials
AzTrials

Wound HealingPhase 2NCT02892435

Prevena™ Incision Management System vs Conventional Management for Wound Healing

A Phase 2 study testing incisional negative pressure wound therapy and conventional dressing in people with Wound Healing and Prevena, run by Ospedale Misericordia e Dolce at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Comparison in abdominal wound healing after contaminated or dirty surgery with incisional negative pressure wound therapy versus standard dressing. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Wound Healing, Prevena, Dirty Abdominal Surgery
What is being tested?
incisional negative pressure wound therapy and conventional dressing
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteItaly
Study dates
Nov 2014to Dec 2017
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • abdominal surgery
  • open surgery
  • contaminated or dirty surgery

Who cannot join

  • not abdominal surgery
  • mininvasive surgery
  • clean surgery

Trial locations and contacts

1 site in 1 country.

Italy1 site, 1 recruiting
  • Misericordia e Dolce Hospital

    Prato, Po, 59100

    Francesco Feroci, MD, +393398382381, fferoci@yahoo.it

    Luca Romoli, MD

    Recruiting

Other trials in Italy

About this study

Official title: Wound Healing After Dirty/Contaminated Emergency Abdominal Surgery: Prevena™ Incision Management System vs Conventional Management

Comparison in abdominal wound healing after contaminated or dirty surgery with incisional negative pressure wound therapy versus standard dressing.

Read the detailed description

All patients submitted to contaminated or dirty abdominal surgery have more risk of surgical site infections. The investigators intend to randomize this kind of patients and comparison wound healing after dressed with incisional negative pressure wound therapy or standard dressing.

In the study group INPWT (Prevena) is positioned immediately next surgery and dressed for six days. Every patients will be medicate in sixth, ninth, fifteenth and thirtieth day after surgery and will be valued wound healing with a scale score.

Moreover for each patient it will be assessed risk developing wound complications through possum score and comorbidities.

Being tested
incisional negative pressure wound therapy, conventional dressing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • incisional negative pressure wound therapyDevice

    Also called Prevena - KCI

    positioning incisional negative pressure therapy over closed wound.

  • conventional dressingDevice

    positioning conventional dressing

Study groups in NCT02892435
Study groupRoleWhat they receive
Prevena armExperimentalpatients underwent to contaminated/dirty surgery who positioned incisional negative pressure wound therapy and kept for six days
Receives: Device: incisional negative pressure wound therapy
Control armActive comparatorpatients underwent to contaminated/dirty surgery who positioned conventional dressing
Receives: Device: conventional dressing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Surgical Site Infection (SSI) reduction

    quantify SSI decrease after incisional negative pressure wound therapy

    Measured: 7 months

Secondary outcomes (1)
  1. Surgical Site Infection (SSI) and risk factors as diabetis, obesity and cancer

    check connection between wound complications and risk factors and showing if Incisional Negative Pressure Wound Therapy (INPWT) could reduce effects of these risk factors

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2016 (estimated)
  2. Study startNov 2014
  3. Primary completionDec 2016 (estimated)
  4. Study completionDec 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02892435
Sponsor's protocol ID
012/2015
Status last verified
Sep 2016
First submitted
19 May 2015
Last updated
8 Sep 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing incisional negative pressure wound therapy and conventional dressing in people with Wound Healing and Prevena, run by Ospedale Misericordia e Dolce at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Alessia Garzi, MD (0574804612 ext. +39, alessia.garzi@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Surgical Site Infection (SSI) reduction (time frame: 7 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in